A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Drug Acquiring Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a robust trade exists on Telegram, where communities with numerous of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Express Concerns
However, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals administering products of unknown origin.
Some experts stated the demand for retatrutide could be linked to the rising cost of approved slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.
Service Reaction and Content Removal
Based on the social media company, the service has taken down problematic content and prohibited related keywords and search suggestions. The company stated it was dedicated to maintaining the platform safe and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Research also found communities with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, filled with photos of weight loss, positive testimonials and detailed guides for mixing or administering at residence.
After moments of joining one group, a seller shared WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.
Product Details and Costs
Inside these groups, messages display dark colored parcels with Royal Mail labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how long a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram said it actively monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is valid, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has previously encountered patients injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose patients to possibly significant health risks”.
